Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer

doi:10.3748/wjg.v28.i33.4744

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7274)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

394

WORD

HTML

4416

Figures (1-5)

310

Tables (1-3)

247

Sum=5457

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

201

Download

380

Sum=581

Publishing Process of This Article

Item

Count

Browse

322

Download

914

Sum=1236

Sep 7, 2022 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 7, 2022; 28(33): 4744-4761
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4744

Open in New Tab Full Size Figure Download Figure

Figure 1 Representation of individual colorectal cancer subtypes.

Open in New Tab Full Size Figure Download Figure

Figure 2 Three genetic and epigenetic aberrations of colorectal cancer formation. LOH: Loss of heterozygosity; TGF: Transforming growth factor.

Open in New Tab Full Size Figure Download Figure

Figure 3 Transforming growth factor-beta superfamily signal transduction. TGF: Transforming growth factor; EMT: Epithelial-mesenchymal transition; ERK: Extracellular signal-regulated kinase; BMP: Bone morphogenetic protein; SMAD: Small mothers against decapentaplegic homolog.

Open in New Tab Full Size Figure Download Figure

Figure 4 Inhibitory effect of small mothers against decapentaplegic homolog 7 on the process of colorectal cancer development. TGF: Transforming growth factor; SMAD: Small mothers against decapentaplegic homolog.

Open in New Tab Full Size Figure Download Figure

Figure 5 Inhibition strategies of transforming growth factor-β signaling pathway and miRNAs targets for colorectal cancer treatment. TGF: Transforming growth factor; SMAD: Small mothers against decapentaplegic homolog.

Citation: Maslankova J, Vecurkovska I, Rabajdova M, Katuchova J, Kicka M, Gayova M, Katuch V. Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer. World J Gastroenterol 2022; 28(33): 4744-4761
URL: https://www.wjgnet.com/1007-9327/full/v28/i33/4744.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i33.4744